Literature DB >> 10360993

Complementary and alternative medicine use by patients with inflammatory bowel disease: An Internet survey.

R J Hilsden1, J B Meddings, M J Verhoef.   

Abstract

OBJECTIVES: To determine the degree and determinants of the use of complementary and alternative medicine (CAM) by patients with inflammatory bowel disease (IBD) with the use of the Internet and to compare the results with those found by using a similar survey in patients attending gastroenterology clinics in Calgary, Alberta. SUBJECTS AND METHODS: A cross-sectional survey of 263 patients with IBD with the use of a World Wide Web-based, structured questionnaire was conducted.
RESULTS: Complementary therapies had been used by 46% of patients in the previous two years. Current use was reported by 34%. Vitamins, herbal products and natural health practices were the most commonly reported therapies. Side effects and lack of effectiveness of standard therapies were the most commonly cited reasons for seeking complementary medicine. However, despite this, respondents who had previously received surgery, or intravenous or oral steroids were less likely to be current CAM users. Important differences between the determinants of and reasons for CAM use in the present study and those of a similar study of IBD patients in a local tertiary care setting were noted.
CONCLUSIONS: Complementary medicine use is common in patients with IBD. Differences in the determinants of and reasons for CAM use noted between the present Internet sample and a gastroenterology clinic sample suggest that conclusions from the present study and from previous studies based only on clinic samples provide a limited view of CAM use by people with IBD. More comprehensive assessments are needed.

Entities:  

Mesh:

Year:  1999        PMID: 10360993     DOI: 10.1155/1999/586765

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  9 in total

1.  Methods for the design and administration of web-based surveys.

Authors:  T K Schleyer; J L Forrest
Journal:  J Am Med Inform Assoc       Date:  2000 Jul-Aug       Impact factor: 4.497

2.  Randomized testing of alternative survey formats using anonymous volunteers on the World Wide Web.

Authors:  D S Bell; C M Mangione; C E Kahn
Journal:  J Am Med Inform Assoc       Date:  2001 Nov-Dec       Impact factor: 4.497

3.  Internet-based data inclusion in a population-based European collaborative follow-up study of inflammatory bowel disease patients: description of methods used and analysis of factors influencing response rates.

Authors:  Frank L Wolters; Gilbert van Zeijl; Jildou Sijbrandij; Frederik Wessels; Colm O'Morain; Charles Limonard; Maurice G Russel; Reinhold W Stockbrugger
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

4.  How patients view probiotics: findings from a multicenter study of patients with inflammatory bowel disease and irritable bowel syndrome.

Authors:  MaryBeth Mercer; Margaret A Brinich; Gail Geller; Krista Harrison; Janelle Highland; Katherine James; Patricia Marshall; Jennifer B McCormick; Jon Tilburt; Jean-Paul Achkar; Ruth M Farrell; Richard R Sharp
Journal:  J Clin Gastroenterol       Date:  2012-02       Impact factor: 3.062

Review 5.  Revisiting Inflammatory Bowel Disease: Pathology, Treatments, Challenges and Emerging Therapeutics Including Drug Leads from Natural Products.

Authors:  Karma Yeshi; Roland Ruscher; Luke Hunter; Norelle L Daly; Alex Loukas; Phurpa Wangchuk
Journal:  J Clin Med       Date:  2020-04-28       Impact factor: 4.241

Review 6.  Chinese medical herbs for chemotherapy side effects in colorectal cancer patients.

Authors:  W Taixiang; A J Munro; L Guanjian
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

Review 7.  Using the Internet for surveys and health research.

Authors:  Gunther Eysenbach; Jeremy Wyatt
Journal:  J Med Internet Res       Date:  2002 Apr-Nov       Impact factor: 5.428

8.  Factors associated with the use of probiotics in patients with inflammatory bowel disease.

Authors:  Claire Louise Agathou; Ian Lp Beales
Journal:  F1000Res       Date:  2013-03-04

9.  A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn's disease.

Authors:  Ingvar Bjarnason; Guy Sission; Bu'Hussaine Hayee
Journal:  Inflammopharmacology       Date:  2019-05-03       Impact factor: 4.473

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.